Article Versions Notes

Lin Y-K, Yeh C-T, Kuo K-T, Yadav VK, Fong I-H, Kounis NG, Hu P, Hung M-Y. Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression. Antioxidants. 2021; 10(8):1280. https://doi.org/10.3390/antiox10081280

Lin, Yen-Kuang, Chi-Tai Yeh, Kuang-Tai Kuo, Vijesh Kumar Yadav, Iat-Hang Fong, Nicholas G. Kounis, Patrick Hu, and Ming-Yow Hung. 2021. "Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression" Antioxidants 10, no. 8: 1280. https://doi.org/10.3390/antiox10081280

Lin, Y.-K., Yeh, C.-T., Kuo, K.-T., Yadav, V. K., Fong, I.-H., Kounis, N. G., Hu, P., & Hung, M.-Y. (2021). Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression. Antioxidants, 10(8), 1280. https://doi.org/10.3390/antiox10081280